simvastatin has been researched along with Kidney Tubular Necrosis, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Also, MA; Bastida, C; Letang, E; Miró, JM; Pericas, JM; Tuset, M | 1 |
| Basta-Jovanović, G; Chatterjee, PK; Nesic, Z; Prostran, M; Radojevic-Skodrić, S; Stojanović, R; Thiemermann, C; Todorovic, Z; Velicković, R | 1 |
2 other study(ies) available for simvastatin and Kidney Tubular Necrosis, Acute
| Article | Year |
|---|---|
[Rhabdomyolysis and severe hepatotoxicity due to a drug-drug interaction between ritonavir and simvastatin. Could we use the most cost-effective statin in all human immunodeficiency virus-infected patients?].
Topics: Antiretroviral Therapy, Highly Active; Atorvastatin; Chemical and Drug Induced Liver Injury; Comorbidity; Contraindications; Cost-Benefit Analysis; Cytochrome P-450 CYP3A Inhibitors; Drug Substitution; Drug Synergism; Dyslipidemias; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubular Necrosis, Acute; Middle Aged; Rhabdomyolysis; Ritonavir; Simvastatin | 2014 |
Acute protective effects of simvastatin in the rat model of renal ischemia-reperfusion injury: it is never too late for the pretreatment.
Topics: Animals; Creatinine; Disease Models, Animal; Drug Administration Schedule; Edema; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Injections, Intravenous; Kidney; Kidney Tubular Necrosis, Acute; Male; Rats; Rats, Wistar; Reperfusion Injury; Simvastatin; Sodium; Time Factors | 2008 |